The Mahamaya Lifesciences Ltd IPO date has been confirmed from November 11, 2025, and closes on November 13, 2025. Read the post to learn about Mahamaya Lifesciences Ltd IPO GMP.
Mahamaya Lifesciences IPO is a book build issue of ₹70.44 crores. The issue is a combination of fresh issue of 0.56 crore shares aggregating to ₹64.28 crores and offer for sale of 0.05 crore shares aggregating to ₹6.16 crores. Mahamaya Lifesciences IPO price band is set at ₹108.00 to ₹114.00 per share . The lot size for an application is 1,200. The minimum amount of investment required by an individual investor (retail) is ₹2,73,600.00 (2,400 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (3,600 shares), amounting to ₹4,10,400.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
Nov 11 – Nov 13Price Range
₹108 to ₹114 per shareFace Value
₹10 per shareGMP
₹0Mahamaya Lifesciences Ltd IPO GMP
The Mahamaya Lifesciences Ltd IPO GMP Today is ₹0.
IPO Overview
Mahamaya Lifesciences IPO opens for subscription on Nov 11, 2025 and closes on Nov 13, 2025. The allotment for the Mahamaya Lifesciences IPO is expected to be finalized on Nov 14, 2025. Mahamaya Lifesciences IPO will list on BSE SME with a tentative listing date fixed as Nov 18, 2025.
| IPO Date | November 11, 2025 to November 13, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | ₹108 to ₹114 per share |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 61,78,800 shares (aggregating up to ₹70.44 Cr) |
| Reserved for Market Maker | 3,09,600 shares (aggregating up to ₹3.53 Cr)Mansi Share & Stock Broking Pvt.Ltd. |
| Fresh Issue (Ex Market Maker) | 53,29,200 shares (aggregating up to ₹60.75 Cr) |
| Offer for Sale | 5,40,000 shares of ₹10 (aggregating up to ₹6.16 Cr) |
| Net Offered to Public | 58,69,200 shares (aggregating up to ₹66.91 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,77,66,200 shares |
| Share Holding Post Issue | 2,34,05,000 shares |
Mahamaya Lifesciences Ltd Financial Information
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Total Income | 84.04 | 267.17 | 162.83 | 137.40 |
| Profit After Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| EBITDA | 8.04 | 24.64 | 13.36 | 8.91 |
| NET Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Reserves and Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
| Amount in ₹ Crore | ||||
Mahamaya Lifesciences Ltd IPO Timeline
| IPO Open Date | Tue, Nov 11, 2025 |
| IPO Close Date | Thu, Nov 13, 2025 |
| Tentative Allotment | Fri, Nov 14, 2025 |
| Initiation of Refunds | Mon, Nov 17, 2025 |
| Credit of Shares to Demat | Mon, Nov 17, 2025 |
| Tentative Listing Date | Tue, Nov 18, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Nov 13, 2025 |
Company Profile
Founded in 2002, Mahamaya Lifesciences has been driven by a deep commitment to enhancing Indian agriculture. Guided by the vast experience of its promoter in the agrochemical sector, the company has focused its efforts on registering and developing vital molecules essential for crop protection. At Mahamaya, we aim to set new benchmarks in the crop protection industry by promoting safe, sustainable, and farmer-friendly pesticide usage. Growing hand in hand with our farmers, we consider it our moral responsibility to express gratitude by delivering high-quality agro products that empower them. As a responsible producer, our mission aligns with the United Nations Sustainable Development Goals — striving toward zero hunger, increased agricultural productivity, and a better quality of life for every farmer.
Registrar Info
| Name | Kfin Technologies Ltd. |
| Phone number | 04067162222, 04079611000 |
| Email ID | mahamaya.ipo@kfintech.com |
| Website | https://ipostatus.kfintech.com/ |
Contact Details
| Name | Mahamaya Lifesciences Ltd |
| Phone number | +91-1146561474 |
| Email ID | cs@mahamayalifesciences.com |
| Website | https://www.mahamayalifesciences.com/ |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Mahamaya Lifesciences Ltd IPO FAQs
When Mahamaya Lifesciences IPO will open?
The Mahamaya Lifesciences IPO opens on November 11, 2025 and closes on November 13, 2025.
What is the lot size of Mahamaya Lifesciences IPO?
Mahamaya Lifesciences IPO lot size is 1200, and the minimum amount required for application is ₹2,73,600, with 2 lots being the minimum application size.
When is Mahamaya Lifesciences IPO listing date ?
The Mahamaya Lifesciences IPO listing date is not yet announced. The tentative date of Mahamaya Lifesciences IPO listing is Tuesday, November 18, 2025.